<DOC>
	<DOCNO>NCT00418392</DOCNO>
	<brief_summary>The estimate recurrence rate primary spontaneous pneumothorax 23-50 % first episode , optimal treatment remain unknown . In recently publish British Thoracic Society ( BTS ) guideline , simple aspiration recommend first line treatment primary pneumothoraces require intervention . However , 1 year recurrence rate procedure high 25-30 % , make inappropriate standard care . Intrapleural instillation chemical irritant ( chemical pleurodesis ) effective way shorten duration air leak reduce rate recurrent spontaneous pneumothorax surgical non-surgical patient . Many chemical irritant ( tetracycline , talc , minocycline ) use decrease rate recurrence spontaneous pneumothorax . Tetracycline , commonly use irritant , longer available . Talc insufflation pleural cavity safe effective primary spontaneous pneumothorax . However , apply either surgical medical thoracoscopy . Minocycline , derivative tetracycline , effective tetracycline induce pleural fibrosis rabbit . In previous study , show additional minocycline pleurodesis safe convenient procedure decrease rate ipsilateral recurrence thoracoscopic treatment primary spontaneous pneumothorax . In present study , additional minocycline pleurodesis randomly administer patient first episode primary spontaneous pneumothorax simple aspiration test reduce rate recurrence .</brief_summary>
	<brief_title>Intrapleural Minocycline After Simple Aspiration Prevention Primary Spontaneous Pneumothorax</brief_title>
	<detailed_description>Background : Primary spontaneous pneumothorax commonly occur young , tall , lean male ( 1 , 2 ) . The estimated recurrence rate 23-50 % first episode ( 3 ) . Optimal treatment patient present first episode primary spontaneous pneumothorax remain unknown . In recently publish British Thoracic Society ( BTS ) guideline ( 4 ) , simple aspiration recommend first line treatment primary pneumothoraces require intervention . However , 1 year recurrence rate procedure high 26-30 % ( 5 ) , make inappropriate standard care . Intrapleural instillation chemical irritant ( chemical pleurodesis ) effective way shorten duration air leak reduce rate recurrent spontaneous pneumothorax surgical non-surgical patient ( 6 , 7 ) . Light et al . show intrapleural tetracycline effective reduce rate ipsilateral recurrence patient spontaneous pneumothorax ( 7 ) . However , recently publish guideline recommend chemical pleurodesis attempt patient either unwilling unable undergo surgery rate recurrence pneumothoraces surgical intervention either thoracotomy VATS , without surgical pleurodesis , far less chemical pleurodesis ( 4 , 8 ) . As result , chemical pleurodesis rarely use primary spontaneous pneumothorax , effect additional chemical pleurodesis simple aspiration prevent recurrence pneumothoraces never evaluate . Tetracycline , commonly use irritant , longer available . Minocycline , derivative tetracycline , effective tetracycline induce pleural fibrosis rabbit ( 9 ) . In previous study , show additional minocycline pleurodesis safe convenient procedure associate low rate prolong air leak ipsilateral recurrence thoracoscopic treatment primary spontaneous pneumothorax ( 10 , 11 ) . In present study , additional minocycline pleurodesis randomly administer patient first episode primary spontaneous pneumothorax simple aspiration test reduce rate recurrence . This study comply protocol , GCP applicable requirement Institutional Review Boards ( IRB ) NTUH Far Eastern Memorial Hospital . Patients Methods : Study design This study prospective , randomize , control trial evaluate additional minocycline pleurodesis simple aspiration effective prevent recurrence primary spontaneous pneumothorax . Primary Objective The primary end point compare rate ipsilateral recurrence minocycline observation group simple aspiration pneumothorax . Secondary Objectives 1 . Safety profile minocycline pleurodesis 2 . Early result , include immediate success rate , one-week success rate , complication rate , rate hospitalization , duration hospitalization , degrees chest pain . 3 . Long-term effect minocycline pleurodesis , include degree residual chest pain pulmonary function test . Eligibility criteria Patients must meet ALL inclusion criterion entry study : 1 . Male female . 2 . Age 15 40 year old . 3 . First episode spontaneous pneumothorax . 4 . Symptomatic ( dyspnea chest pain ) rim air &gt; 2cm CXR require simple aspiration 5 . Complete nearly complete persistent lung expansion immediately follow manual aspiration 6 . Organ Function Requirements : 1 . Adequate hematological function ( Hb &gt; 10 g/dl , ANC &gt; 1.5 x 109/L , platelet &gt; 100 x 109/L ) 2 . Normal renal hepatic function : serum creatinine &lt; 1 x ULN , SGPT SGOT &lt; 2.5 x ULN , alkaline phosphatase &lt; 5 x ULN 7 . Written inform consent The exclusion criterion : 1 . With underlying pulmonary disease ( asthma , chronic obstructive pulmonary disease , bronchiectasis , etc ) 2 . With hemothorax tension pneumothorax require chest tube insertion operation 3 . A history previous pneumothorax 4 . A history previous ipsilateral thoracic operation 5 . Allergy tetracycline minocycline 6 . Pregnant lactating patient . 7 . Other serious concomitant illness medical condition : 1 . Congestive heart failure unstable angina pectoris . 2 . History myocardial infarction within 1 year prior study entry . 3 . Uncontrolled hypertension arrhythmia . 4 . History significant neurologic psychiatric disorder , include dementia seizure . 5 . Active infection require i.v . antibiotic . Subjects unwilling undergo randomization , treatment , follow-up procedure remove study . Subjects also withdraw trial time point . Randomization : Patients randomize center separate random number list one two treatment group use computer-generated table numerically correspond treatment group . The trial treatment randomization code maintain end study broken investigator blind randomization procedure . Manual aspiration Manual aspiration perform follow : patient seat semi-supine position . After skin disinfection field preparation , small-caliber pig-tail catheter ( 6-10 French ) introduce local anesthesia 2 % lidocaine second intercostal space , midclavicular line . After catheter enters pleural space , catheter fix skin use sterile adhesive tape connect via three-way valve 50-ml syringe . Air manually aspirate , resistance felt air longer aspirate . Thereafter , chest X-ray perform catheter place . Minocycline pleurodesis In minocycline group , 30 mL 1 % lidocaine hydrochloride ( 300mg ) follow solution 30 mL normal saline contain 300 mg minocycline ( Mirosin® , Taiwan Panbiotic Laboratories , Kaohsiung , Taiwan ) instill pleural cavity pig-tail catheter chest tube . In observation group , nothing administer . Administration chemical pleurodesis agent prohibit study period . Intramuscular meperidine hydrochloride ( Demerol® , 50mg/ampule ) administer every 4 6 hour accord patient 's request pain become intolerable , could relieve oral analgesic , visual analogue scale great 7 . Chest radiography perform immediate postoperatively next morning . VAS evaluate immediately 6 hour later minocycline administration . Study Endpoints : The primary end point rate ipsilateral recurrence procedure . Secondary end point include safety , early result , long-term effect minocycline pleurodesis . Immediate success rate : define complete nearly complete persistent lung expansion immediately follow manual aspiration . Immediate success chest tube drainage define complete lung expansion , absence air leakage , chest drain removal within 24 hour catheter placement . One week success rate define complete persistent lung expansion one week first attempt aspiration tube insertion . One-year success : absence recurrent pneumothorax 1-year follow-up period . . Safety assessment : Safety assessment consist monitor record toxicity , adverse event , safety laboratory examination , vital sign , physical examination . The adverse event report graded mild , moderate , severe , life-threatening . Adverse event tabulate incidence rate calculate . Sample size estimation : A sample size 300 patient ( 150 group ) need reach clinical significance ( .05 level power 0.9 ) minocycline reduce recurrence rate 30 % 15 % drop rate 10 % . A planned interim analysis conduct enrollment 150 patient least 12 month follow-up . Statistical analysis perform intent-to-treat basis rather actual treatment basis . Follow-up After discharge hospital , patient follow outpatient clinic 1 week , 1 month , 3 month , 6 month chest radiography perform . Follow-ups conduct every 6 month register nurse blind group allocation telephone conversation , accord standard questionnaire include patient return work school , whether recurrence occur , happen , treat . Residual postoperative chest pain evaluate pain score 0 5 , 0 pain free ; 1 occasional discomfort ; 2 occasional use analgesic ; 3 use nonopiate analgesic ; 4 regular pain use opiate ; 5 severe intractable pain . All patient follow least 12 month . Patients come back clinic visit emergency department whenever chest pain , dyspnea , sign related recurrence pneumothorax . Pulmonary function analysis Pulmonary function test perform patient able attend hospital outpatient appointment least 6 month surgery . Forced vital capacity ( FVC ) force expiratory volume 1 second ( FEV1.0 ) measure use spirometer Microspiro HI-298 ( Chest Corporation , Tokyo , Japan ) patient seat . A minimum three acceptable force expiratory maneuver perform best one select analysis . Data collection statistical analysis The clinical data , duration chest drainage , length hospital stay , complication , request dos meperidine , data VAS collect . Continuous variable age weight express mean + standard deviation analyze two sample t-test . Categorical variable gender smoke status present frequency ( % ) analyze Fisher 's exact test . Intensity postoperative pain measure VAS ( 0 10 ) summarize mean ( 95 percent confidence interval ) compare Wilcoxon rank-sum test . Scores residual chest pain analyze Wilcoxon rank-sum test . Freedom recurrence analyze Kaplan-Meier method , comparison make log-rank test . Reference : 1 . Gobbel WG Jr , Rhea WG , Nelson IA , Daniel RA Jr. Spontaneous pneumothorax . J Thorac Cardiovasc Surg 1963 ; 46:331-345 . 2 . Lichter J , Gwynne JF . Spontaneous pneumothorax young subject . Thorax 1971 ; 25:409-417 . 3 . Light RW . Management spontaneous pneumothorax . Am Rev Respir Dis 1993 ; 148:245-258 . 4 . Henry M , Arnold T , Harvey J ; Pleural Diseases Group , Standards Care Committee , British Thoracic Society . BTS guideline management spontaneous pneumothorax . Thorax 2003 ; 58 ( Supple 2 ) :39-52 . 5 . Noppen M , AJRCCM , 2003 6 . Hatta T , Tsubota N , Yoshimura M , Yanagawa M. Intrapleural minocycline postoperative air leakage control malignant pleural effusion . Kyobu Geka 1990 ; 43:283-286 . 7 . Light RW , O'Hara VS , Moritz TE , McElhinney AJ , Butz R , Haakenson CM , Read RC , Sassoon CS , Eastridge CE , Berger R , et al . Intrapleural tetracycline prevention recurrent spontaneous pneumothorax . JAMA 1990 ; 264:2224-2230 . 8 . Baumann MH , Strange C , Heffner JE , Light R , Kirby TJ , Klein J , Luketich JD , Panacek EA , Sahn SA ; AACP Pneumothorax Consensus Group . Management spontaneous pneumothorax : American College Chest Physicians Delphi consensus statement . Chest 2001 ; 119:590-602 . 9 . Light RW , Wang NS , Sassoon CSH , Gruer SE , Vargas FS . Comparison effectiveness tetracycline minocycline pleural sclerosing agent rabbit . Chest 1994 ; 106:577-582 . 10 . Chen JS , Hsu HH , Kuo SW , Tsai PR , Chen RJ , Lee JM , Lee YC : Effects additional minocycline pleurodesis thoracoscopic procedure primary spontaneous pneumothorax . Chest 2004 ; 125:50-55 . 11 . Chen JS , Hsu HH , Chen RJ , Kuo SW , Huang PM , Tsai PR , Lee JM , Lee YC : Additional minocycline pleurodesis thoracoscopic surgery primary spontaneous pneumothorax . Am J Respir Crit Care Med 2006 ; 173 : 548-554 .</detailed_description>
	<mesh_term>Pneumothorax</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>1 . Male female . 2 . Age 15 40 year old . 3 . First episode spontaneous pneumothorax . 4 . Symptomatic ( dyspnea chest pain ) rim air &gt; 2cm CXR require simple aspiration 5 . Complete nearly complete persistent lung expansion immediately follow manual aspiration 6 . Organ Function Requirements : Adequate hematological function ( Hb &gt; 10 g/dl , ANC &gt; 1.5 x 109/L , platelet &gt; 100 x 109/L ) Normal renal hepatic function : serum creatinine &lt; 1 x ULN , SGPT SGOT &lt; 2.5 x ULN , alkaline phosphatase &lt; 5 x ULN 7 . Written inform consent 1 . With underlying pulmonary disease ( asthma , chronic obstructive pulmonary disease , bronchiectasis , etc ) 2 . With hemothorax tension pneumothorax require chest tube insertion operation 3 . A history previous pneumothorax 4 . A history previous ipsilateral thoracic operation 5 . Allergy tetracycline minocycline 6 . Pregnant lactating patient . 7 . Other serious concomitant illness medical condition : Congestive heart failure unstable angina pectoris . History myocardial infarction within 1 year prior study entry . Uncontrolled hypertension arrhythmia . History significant neurologic psychiatric disorder , include dementia seizure . Active infection require i.v . antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>pneumothorax , aspiration , minocycline , pleurodesis</keyword>
</DOC>